Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 06 February 2025
      News
 
  29 January 2025 Medicine shortages: EFPIA proposal for action

Together, all stakeholders share a responsibility and commitment to building resilient supply chains that ensure patients...

Read more →
 
 
 
      Blogs
 
  03 February 2025 United by Unique: a call for people-centred cancer care on World Cancer Day 2025

Cancer is more than just a medical diagnosis; it is a deeply personal experience. Each person's journey with cancer...

Read more →
 
 
 
  03 February 2025 Unlocking cross-border clinical trials for patients in Europe

The public consultation for the EU-X-CT draft recommendations has been extended, you have until 31 March 2025 to share...

Read more →
 
 
 
      Events
 
 
25 FEB 2025
  JLABS | Road to first-in-human trials for small molecules Leiden & virtual

Johnson & Johnson Innovation – JLABS invites you for a program that takes an in-depth look into essential aspects of...

Learn more →
 
 
 
19 MAR 2025
  Cancer Care 2030: From policy ambition to impact Brussels, Belgium

Join us on 19 March in Brussels to discuss how we can work together to accelerate progress to improve cancer care

Learn more →
 
 
      Register for our upcoming webinar "The case for investing in a healthier future for the European Union"

In a time of slow economic growth, geopolitical instability, and increasing pressures on healthcare systems, strategic investment in health has never been more critical. Our upcoming report highlights the health and economic benefits of investing in prevention, early detection, and treatment of non-communicable diseases (NCDs) such as stroke, ischemic heart disease, type 2 diabetes, COPD, and breast cancer across the EU. 

During this webinar, we will explore: 

  • Why investing in health is essential for economic sustainability and long-term growth. 
  • How targeted interventions can improve patient outcomes and generate substantial returns on investment. 
  • How the EU can support Member States in making strategic investments in health, including through the European Semester process.

Register here.

 
 
      What we are reading
Study on mapping and evaluating the implementation of the Europe’s Beating Cancer Plan 06 February 2025  (European Union) Read more →
#AlwaysInnovating: Pharmaceutical Industry Facts & Figures 06 February 2025  (IFPMA) Read more →
PHARMECO plans ‘green revolution’ in medicines manufacture 05 February 2025  (IHI) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe